All Online

61 - 72 of 84 results

Refine

Active filters

Infectious Diseases
0.5 CME CREDIT

Unlike HIV with rates of mortality that decline yearly, TB remains the leading infectious cause of death worldwide, accounting for 1.3 million deaths in 2016. Approximately 2 billion people in the world and 10 to 15 million Americans have latent TB infection (LTBI). Although they are not infectious, up to 10% each year are at risk of progression to active disease, depending on their risk factors and co-morbidities. This presentation will compare modalities to diagnose LTBI: the tuberculin skin test (or PPD) and the interferon gamma release assay (e.g., the quantiferon gold blood test). The faculty will discuss which patients are at high risk for progression to TB disease and the role of preventive chemotherapy. Finally, you will learn more about the emerging global storm that awaits us as diabetes becomes epidemic and merges with TB, as there is a 2-4-fold increased risk for TB in patients with diabetes.


1 CME CREDIT

With the COVID-19 pandemic moving through the country, it is important for clinicians to have the most up-to-date information. Join this session with Dr. Peter Libby and Dr. Erin Bohula to learn about the cardiovascular complications of COVID-19 and how you can help patients facing these issues. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/08/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the sixth episode of Pri-Med’s weekly web series on COVID-19, faculty will interview a patient who recently recovered from COVID-19. This patient will share his experience from diagnosis to recovery, including thoughts on his interaction with the healthcare system during this unique time. This session aims to give clinicians a better understanding of the patient perspective, and helps us recognize where there is potential for improvement in caring for patients with COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/07/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the ninth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss ongoing treatment considerations and controversies. They will review the potential role of steroids and vitamins in treating and preventing COVID-19, as well as the safety of commonly used medications including ibuprofen, ARBs, and ACE inhibitors in patients with or at risk for COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 5/28/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the fourth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the clinical presentation and diagnosis of COVID-19. In addition to describing the various methods of COVID-19 testing, they will review data regarding the presentation of patients with COVID-19, including history, physical exam, labs, and imaging findings. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/23/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the tenth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss cardiovascular issues related to COVID-19. They will review the relationship between inflammation and cardiac complications in COVID-19 and discuss the potential acute cardiac consequences of COVID-19; lastly, they will describe strategies for evaluating patients with cardiac consequences of COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/2/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the seventh episode of Pri-Med’s weekly web series on COVID-19, faculty will start off a multi-episode spanning discussion on COVID-19 treatment by analyzing recent evidence of antiviral therapies. They will also review the current recommendations regarding their use in patients with COVID-19. Therapies to be discussed in this episode will include: • Convalescent Plasma • Camostat Mesilate • Lopinavir/Ritonavir • Hydroxychloroquine and Chloroquine • Remdesivir Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/14/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the thirteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss recent trends in COVID-19 infection numbers and will review new findings on immune response after COVID-19 infection and the use of corticosteroids in hospitalized patients requiring mechanical ventilation or oxygen.


1 CME CREDIT

In the fifth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss strategies for adapting clinical practice to virtual platforms and explain how telehealth has changed as a result of the COVID-19 pandemic. They will review requirements for providing various types of telehealth visits (audio only vs. audio plus video) and share practical advice on getting reimbursed for these encounters, including review of common billing codes. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 4/28/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the first episode of Pri-Med’s weekly web series on COVID-19, faculty will review the unique aspects of COVID-19’s spread and impact, including the epidemiology, viral characteristics, common clinical manifestations and complications of infection. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/31/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the second episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the risks to healthcare workers associated with COVID-19. They will review current data on systems-based solutions to reduce transmission risk, the importance of personal protective equipment (PPE), and when to discontinue precautions in patients with resolved COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/09/2020, and they are subject to change as new information is published.


1 CME CREDIT

In the third episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss important information for clinicians to relay to their patients regarding COVID-19. They will review current recommendations around how patients should be instructed to protect themselves and high-risk family members, how to monitor symptoms when sick, and how to determine when it’s appropriate to end self-isolation. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/16/2020 and they are subject to change as new information is published.